In 1969, a controversial experiment used amphetamines to induce psychosis in healthy volunteers—changing our understanding of ...

Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...

Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...

A University of Kentucky scientist has found two markers that can be collected through a cheek swab and indicate the presence ...

PURCHASE, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative ...

"We're living in a toxic culture now... that affects children by affecting the capacity of parents to be fully present for ...

If you are stuck at the same weight despite eating well and working out, a US-trained doctor recommended focusing on the ...

New consensus recommendations were developed to provide a framework for screening and treating tardive dyskinesia in a long-term care setting.

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through the clinic.

A study published in Gut Microbes looks at dietary and gut-derived metabolites predicting early cognitive decline. Prof Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, said: ...

Feeling constantly tired might have less to do with your schedule and more to do with what’s sitting in your medicine cabinet ...

Every January, millions of people make the same resolution and follow the same arc: restrict calories, lose some weight in ...